about
The clinical recognition of coronary heart diseaseA simple nephelometric method for the determination of human serum betalipoproteinWeight gain from simple overeating. II. Serum lipids and blood volumeTissue distribution of C14 after the intravenous injection of labeled chylomicrons and unesterified fatty acids in the rat.Genetic studies on idiopathic hypercholesteremiaA study of serum beta lipoprotein and total cholesterol variability and its relation to age and serum level in adult human subjects.Effects of heparin on the lipoproteins in hyperlipemia; electrophoretic study of the serum alpha and beta lipoproteins after their separation by fractionation of the plasma proteins or ultracentrifugal flotation.The metabolism of chylomicra. I. The removal of palmitic acid-1-C14 labeled chylomicra from dog plasma.Early effects of fat ingestion on lipids and lipoproteins of serum in man.SERUM beta-LIPOPROTEIN LEVELS IN HEALTH AND DISEASE, AS DETERMINED BY THE NEPHELOMETRIC METHOD WITH AMYLOPECTIN SULFATE AS REAGENT.Atherosclerosis; inevitable or controllable?Myocardial infarction associated with hypercholesterolaemia in a young eunuch.BLOOD VISCOSITY IN HEALTHY SUBJECTS AND PATIENTS WITH CORONARY HEART DISEASEThe effects of cholesterol dosage, cortisone, and DCA on total serum cholesterol, lipoproteins, and atherosclerosis in the rabbit.The effect of cortisone on the serum lipids and on the development of experimental cholesterol atherosclerosis in the rabbitExperimental atherosclerosis in Cebus monkeys.Effects of hyperlipoproteinemias and their treatment on the peripheral circulation.Triglyceride-rich lipoproteins and atherosclerosis, from fast to feast.Plasma lipid levels and the diagnosis of coronary arteriosclerosis in England.The influence of anticoagulants on the formation and regression of experimental atherosclerosis.An investigation of serum lipids and lipoproteins by paper electrophoresis.Clearing factor and lipase.High density lipoprotein structure, function, and metabolism: a new Thematic Series.Observations on the aetiology of cholelithiasis.Ischaemic electrocardiograms in symptomless men with a note on the serum lipoproteins.
P2860
Q24685700-A546AD6D-7FB5-4B70-BFDA-8796DECBED6DQ33149605-9CD8D88C-CA94-4112-A610-8D04EB5CF3E4Q33768740-294AD303-1F96-4B5F-9437-1E427CA9889AQ34096755-DAEC0313-CB31-4CDA-AB4A-42EE2D8B61D2Q35252172-A7A3EF62-60C3-4351-9AFB-19E5EC62E9A4Q35266658-F6DC15AA-53DD-47E2-B1C6-BA82C103F87DQ35282653-3FF719D6-5309-4988-BAF7-F6CBD0B2DA60Q35560807-91C90491-668E-4231-B10B-BA377C953AD2Q35563519-781F2E1D-6A74-4CAF-9BC0-8B7BA166435AQ35567790-D055E32D-F507-4E49-B58C-612D65BB7DFDQ35683774-E28A43B3-334D-498B-A1B8-373B0E3E7896Q35693844-7E88417A-2366-47DC-99A4-CE6DABE19258Q35904486-2B52D8FD-DF24-4100-AF55-320B022697EAQ36261758-F1748516-A16F-4D71-B276-B0A1412925CEQ36262101-6CAF3F12-8288-4022-80CC-818EE56E3B46Q36262121-FC31E58D-AAE4-4139-B703-382C58724AD1Q37710196-73C954EF-D635-4F3F-B9D9-0F54B1A63726Q40785330-1C262155-5F8C-4D8F-A367-4EF6E1F38014Q41118064-FB9003D8-A1C5-4032-A91F-4D73F7C3872CQ41848077-5297D1B8-7E79-4C23-8658-1790D2330AE3Q42066718-EBB22EE8-E6DC-420B-9DFC-563448D994BBQ42977770-2CF047F3-9959-4686-B063-A496037E7A82Q43096807-589565B5-5560-4D7A-8F27-7AF4B1D4E897Q55317219-787BA1A6-9988-472F-B630-E1F9C95F9533Q55486101-A5F2ED43-14D9-4629-8EFA-786A8B8F6810
P2860
description
1951 nî lūn-bûn
@nan
1951年の論文
@ja
1951年学术文章
@wuu
1951年学术文章
@zh-cn
1951年学术文章
@zh-hans
1951年学术文章
@zh-my
1951年学术文章
@zh-sg
1951年學術文章
@yue
1951年學術文章
@zh
1951年學術文章
@zh-hant
name
Lipoproteins in atherosclerosis.
@en
Lipoproteins in atherosclerosis.
@nl
type
label
Lipoproteins in atherosclerosis.
@en
Lipoproteins in atherosclerosis.
@nl
prefLabel
Lipoproteins in atherosclerosis.
@en
Lipoproteins in atherosclerosis.
@nl
P2093
P1476
Lipoproteins in atherosclerosis.
@en
P2093
LINDGREN FT
NICHOLS AV
STRISOWER B
P304
P356
10.1016/0002-9343(51)90171-4
P407
P577
1951-09-01T00:00:00Z